Results
eNauka >
Rezultati >
primary analysis of the RANDOMIZED eortc-2139/columbus-ad trial: Adjuvant encorafenib and binimetinib versus placebo in high-risk stage II BRAF-V600E/K melanoma
| Naziv: | primary analysis of the RANDOMIZED eortc-2139/columbus-ad trial: Adjuvant encorafenib and binimetinib versus placebo in high-risk stage II BRAF-V600E/K melanoma | Autori  : | Van, Akkooi Alexander CJ; ...; Matkovic, Suzana; ...; (broj, koautora 38) | Godina: | 2026 | Publikacija: | EUROPEAN JOURNAL OF CANCER | ISSN: | 0959-8049 European Journal of Cancer / EJC Pretraži identifikator |
Tip rezultata: | Naučni članak | Kolacija: | vol. 245 str. 116951-116951 | DOI: | 10.1016/j.ejca.2026.116951 | WoS-ID: | 001836331600001 | Scopus-ID: | 2-s2.0-105045632111 | URI: | https://enauka.gov.rs/handle/123456789/1049340 | Projekat: | Pierre Fabre | Izvor metapodataka: | (Preuzeto iz Nasi u WoS) | M-kategorija: | 21aM21a - Vodeći međunarodni časopis kategorije M21a |
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.